Medicine and Dentistry
Neoplasm
100%
Malignant Neoplasm
89%
Neurofibromatosis Type II
53%
Cancer in Young Adults
52%
Adolescent
45%
Vestibular Schwannoma
43%
Medulloblastoma
40%
Radiation Therapy
35%
Oral Mucositis
24%
Molecular Profiling
24%
Bevacizumab
24%
Central Nervous System
22%
Side Effect
21%
Cancer Registry
21%
Diseases
21%
Mucositis
20%
Brain Tumor
19%
Mortality Rate
17%
Sarcoma
17%
Osteosarcoma
17%
Primitive Neuroectodermal Tumor
16%
COVID-19
16%
Cancer Prognosis
16%
Childhood Cancer
16%
Survival Rate
15%
Placebo
14%
Magnetic Resonance Imaging
14%
Acute Lymphoblastic Leukemia
14%
Biological Marker
13%
Diagnosis
13%
Patient-Controlled Analgesia
13%
Neurinoma
12%
Cancer Therapy
12%
Cancer Research
11%
Infection
11%
Symptomatic Treatment
11%
Cancer Survival
11%
Health Care Cost
11%
Metastatic Carcinoma
10%
Ewing Sarcoma
10%
Cohort Analysis
9%
Translational Research
9%
Continuous Infusion
9%
Personalized Medicine
9%
Germinoma
9%
Central Nervous System Tumor
9%
Meningioma
9%
Brain Metastasis
9%
Clinical Trial Design
9%
Coronavirinae
9%
Nursing and Health Professions
Malignant Neoplasm
69%
Oral Mucositis
40%
Cancer Therapy
21%
Mucosa Inflammation
21%
Confidence Interval
19%
Quality of Life
19%
Central Nervous System Tumor
17%
Medulloblastoma
16%
Placebo
13%
Practice Guideline
13%
Patient Controlled Analgesia
13%
Disease
12%
Adolescent
10%
Neoplasm
10%
Cryotherapy
10%
Brain Tumor
9%
Continuous Infusion
9%
Survival Rate
9%
Radiotherapy
8%
Keratinocyte Growth Factor
8%
Child
8%
Patient-Reported Outcome
8%
Cancer Survival
8%
Clinical Practice
8%
Neuroectoderm Tumor
8%
Melanotic Neuroectodermal Tumor of Infancy
8%
Cancer Research
8%
Mortality Rate
8%
Cancer Epidemiology
8%
Growth Factor
8%
Acute Lymphoblastic Leukemia
8%
Nicotine Withdrawal
8%
Ewing Sarcoma
8%
Side Effect
7%
Cochrane Library
7%
CINAHL
6%
Sham Procedure
6%
Opiate
6%
Infection
6%
Meta Analysis
5%
Medline
5%
Mouth Ulcer
5%
Long-Term Side Effects
5%
Severe Acute Respiratory Syndrome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
98%
Oral Mucositis
40%
Side Effect
20%
Chemotherapy
19%
Mucosa Inflammation
19%
Neurofibromatosis Type 2
16%
Placebo
13%
Infection
11%
Cancer Registry
10%
Survival Rate
9%
Disease
9%
Cancer Epidemiology
9%
Coronavirinae
9%
Keratinocyte Growth Factor
8%
Hematologic Malignancy
8%
Bevacizumab
8%
Acute Lymphoblastic Leukemia
8%
Rare Disease
8%
Growth Factor
8%
Brain Tumor
8%
Mortality Rate
8%
Cytokine
8%
Clinical Trial Design
8%
Thrush
8%
Osteosarcoma
8%
Germ Cell Tumor
8%
SARS Coronavirus
7%
Opiate
6%
Medulloblastoma
5%
Sonidegib
5%
Proteinuria
5%
Sonic Hedgehog Protein
5%
